Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/NG2 stock hub

FRA/NG2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/NG2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/NG2FRA/NG2

—

Loading chart…

In the news

Latest news · FRA/NG2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.3

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-25.6

P25 n/aP50 n/aP75 n/a

ROIC-1.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/NG2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	2,974
Employees Change	57%
Employees Change Percent	1.95
Enterprise value	EUR 2.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 1.7B
Price	EUR 7.78
Price currency	EUR
Rev Per Employee	247,732.27x
Sic	2834
Symbol	fra/NG2
Website	https://www.neogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-30.79%
EV Earnings	-4.3x
EV/EBITDA	29.55x
EV/FCF	432.35x
EV/Sales	2.99x
FCF yield	0.31%
Forward P/E	27.25x
P/B ratio	0.94x
P/S ratio	2.27x
PE Ratio10 Y	153.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.13%
EBITDA Margin	9.33%
FCF margin	0.69%
Gross margin	45.21%
Gross Profit	EUR 333.1M
Gross Profit Growth	-10.95%
Gross Profit Growth Q	-10.24%
Gross Profit Growth3 Y	4.21%
Gross Profit Growth5 Y	13.48%
Net Income	EUR -515.3M
Pretax Margin	-72.15%
Profit Margin	-69.94%
Profit Per Employee	EUR -173,256
ROA	-0.61
Roa5y	2.56
ROCE	-1.12
ROE	-25.57
Roe5y	-5.99
ROIC	-1.31
Roic5y	6.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.75%
Cagr15y	1.1%
Cagr1y	58.91%
Cagr20y	0.53%
Cagr3y	-20.68%
Cagr5y	-27.65%
FCF Growth5 Y	-40.58%
OCF Growth	1.31%
OCF Growth Q	16.66%
OCF Growth10 Y	6.12%
OCF Growth5 Y	-3.9%
Revenue Growth	-3.91x
Revenue Growth Q	-4.43x
Revenue Growth3 Y	6.5x
Revenue Growth5 Y	14.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.24
Assets	EUR 2.8B
Cash	EUR 135.3M
Current Assets	EUR 500.3M
Current Liabilities	EUR 127.7M
Debt	EUR 672.9M
Debt EBITDA	EUR 9.02
Debt Equity	EUR 0.38
Debt FCF	EUR 131
Equity	EUR 1.8B
Interest Coverage	-0.57
Liabilities	EUR 1.1B
Long Term Assets	EUR 2.3B
Long Term Liabilities	EUR 935.8M
Net Cash	EUR -537.6M
Net Cash By Market Cap	EUR -32.12
Net Debt EBITDA	EUR 7.82
Net Debt Equity	EUR 0.3
Net Debt FCF	EUR 105
Tangible Book Value	EUR -243.1M
Tangible Book Value Per Share	EUR -1.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.92
Inventory Turnover	2.6
Net Working Capital	EUR 237.6M
Quick ratio	1.97
Working Capital	EUR 371.9M
Working Capital Turnover	EUR 1.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-50.29%
1Y total return	58.86%
200-day SMA	6.41
3Y total return	-50.1%
50-day SMA	8.17
50-day SMA vs 200-day SMA	50over200
5Y total return	-80.17%
All Time High	41.53
All Time High Change	-81.25%
All Time High Date	2018-09-14
All Time Low	1.59
All Time Low Change	390.49%
All Time Low Date	2006-08-21
ATR	0.2
Ch YTD	27.61
High	7.78
High52	9.8
High52 Date	2026-02-23
High52ch	-20.57%
Low	7.78
Low52	4
Low52 Date	2025-08-01
Low52ch	94.6%
Ma50ch	-4.7%
Price vs 200-day SMA	21.49%
RSI	46.92
RSI Monthly	43.83
RSI Weekly	53.67
Sharpe ratio	0.88x
Sortino ratio	1.49
Total Return	-0.25%
Tr YTD	27.61
Tr15y	17.87%
Tr1m	-4.68%
Tr1w	-2.7%
Tr3m	-12.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -30.4M
Operating margin	-4.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	216,502,867%
Net Borrowing	-84,983,599.6
Shares Insiders	0.52%
Shares Institutions	109.01%
Shares Qo Q	0.12%
Shares Yo Y	0.25%
Short Ratio	3.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -7.3M
Average Volume	135.05x
Bv Per Share	8.17
CAPEX	EUR -53.7M
Ch10y	-50.29
Ch15y	17.87
Ch1m	-4.68
Ch1w	-2.7
Ch1y	58.86
Ch20y	11.06
Ch3m	-12.05
Ch3y	-50.1
Ch5y	-80.17
Ch6m	51.15
Change	1.14%
Change From Open	0.05
Close	7.7
Days Gap	1.04
Depreciation Amortization	99,366,731
Earnings Date	2026-07-28
EBIT	EUR -30.4M
EBITDA	EUR 68.8M
EPS	EUR -2.37
F Score	5
FCF	EUR 5.1M
FCF EV Yield	0.23x
Financing CF	-85,643,867
Fiscal Year End	May
Founded	1,981
Goodwill	888,494,583.6
Income Tax	EUR -16.3M
Investing CF	49,597,412
Is Primary Listing	0
Last Earnings Date	2026-04-09
Last Report Date	2026-02-28
Last Split Date	2021-06-07
Last Split Type	Forward
Ma150	7.01
Ma150ch	11.07%
Ma20	7.89
Ma20ch	-1.38%
Net CF	27,244,936
Next Earnings Date	2026-07-28
Open	7.78
P FCF Ratio	326.9
P OCF Ratio	28.48
Ppne	294,751,591.2
Price Date	2026-05-08
Price EBITDA	EUR 24.34
Relative Volume	3.71x
Revenue	736,755,774x
SBC By Revenue	1.69x
Share Based Comp	12,432,993
Tax By Revenue	-2.21x
Tr20y	11.06%
Tr6m	51.15%
Volume	0
Z Score	0.86

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/NG2 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/NG2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/NG2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+109.0%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/NG2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.9

Neutral momentum band

Price vs 200-day MA

+21.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/NG2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/NG2 stock rating?

fra/NG2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/NG2 analysis?

The full report lives at /stocks/fra/NG2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/NG2?

The latest report frames fra/NG2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/NG2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.